Acoziborole (SCYX-7158) is a novel benzoxaborole derivative developed as an oral treatment for human African trypanosomiasis. It demonstrates potent in vitro activity against Trypanosoma brucei, with an MIC of 0.6 µg/mL for the S427 strain, and has shown promising efficacy in advanced preclinical and clinical studies.
Molecular Weight:
367.1
CAS Number:
[1266084-51-8]
Formula:
C17H14BF4NO3
Target:
Parasite,Others
* VAT and and shipping costs not included. Errors and price changes excepted
